← Back
Data updated: Mar 10, 2026
SEPTODONT
Gastroenterology
SEPTODONT is a generic drug manufacturer focused on Gastroenterology.
1972
Since
8
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (4)
Discontinued (4)
Company Info
- First Approval
- 1972-10-17
- Latest
- 2019-11-26
- Applications
- 8
FDA Sponsor Names
SEPTODONTSEPTODONT INC